MedPath

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer

Early Phase 1
Conditions
Hepatocellular Carcinoma
Liver Neoplasms
Liver Cancer
Metastatic Liver Cancer
Interventions
Biological: ET140202-T cell
Combination Product: Sorafenib combined with ET140202-T cell
Combination Product: TAE combined with ET140202-T cell
First Posted Date
2019-05-29
Last Posted Date
2019-08-08
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
27
Registration Number
NCT03965546
Locations
🇨🇳

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

Neuroimaging and End Stage Renal Disease

Conditions
End Stage Renal Disease
Interventions
Device: magnetic resonance image (MRI)
First Posted Date
2019-05-23
Last Posted Date
2022-04-28
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
192
Registration Number
NCT03961724
Locations
🇨🇳

First Affiliated Hospital of Xian Jiaotong University, Xian, Shaanxi, China

Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension

Not Applicable
Conditions
Hypertension
Interventions
First Posted Date
2019-05-21
Last Posted Date
2019-08-08
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
300
Registration Number
NCT03956823
Locations
🇨🇳

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China

Health Education for Diabetes Mellitus

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Behavioral: Routine Management
Behavioral: Standardized Management
First Posted Date
2019-05-15
Last Posted Date
2020-11-18
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
206
Registration Number
NCT03951168
Locations
🇨🇳

First affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

Learning Curve for Robot-Assisted Gastrectomy in Gastric Cancer

Conditions
Stomach Neoplasms
First Posted Date
2019-05-07
Last Posted Date
2019-05-07
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
100
Registration Number
NCT03940417
Locations
🇨🇳

the First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, Shaanxi, China

Transcutaneous Electrical Acupoint Stimulation for the Treatment of ADHD

Not Applicable
Completed
Conditions
ADHD
Interventions
Device: Transcutaneous Electrical Acupoint Stimulation
First Posted Date
2019-04-17
Last Posted Date
2021-03-15
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
78
Registration Number
NCT03917953
Locations
🇨🇳

Xian Children's Hospital, Xi'an, Shaanxi, China

An Analysis of Clinical Efficacy Based on the Robotic, Laparoscopic, and Open Approach in Radical Resection of Rectal Cancer

Completed
Conditions
Rectal Cancer
Interventions
Procedure: open, laparoscopic, and robotic
First Posted Date
2019-04-10
Last Posted Date
2019-04-10
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
24
Registration Number
NCT03911167
Locations
🇨🇳

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit

Not Applicable
Conditions
Thromboses, Venous
Infection
Economic Problems
Interventions
Other: CVC(Central venous catheter )
Other: PICC(Peripherally inserted central catheter)
First Posted Date
2019-04-09
Last Posted Date
2019-04-23
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
200
Registration Number
NCT03908866
Locations
🇨🇳

First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China

ET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and Lymphoma

Early Phase 1
Conditions
CD19+ Leukemia, B-Cell
CD19+ Lymphoma, B-Cell
Interventions
Biological: ET190L1-ARTEMIS™ T cells - iv high dose
Biological: ET190L1-ARTEMIS™ T cells -iv low dose
Biological: ET190L1-ARTEMIS™ T cells -iv middle dose
First Posted Date
2019-03-29
Last Posted Date
2019-03-29
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
18
Registration Number
NCT03895944
Locations
🇨🇳

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma

Early Phase 1
Terminated
Conditions
Gastric Cancer
Pancreatic Ductal Adenocarcinoma
Interventions
Biological: LCAR-C182A cells
First Posted Date
2019-03-26
Last Posted Date
2020-07-02
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
2
Registration Number
NCT03890198
Locations
🇨🇳

The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath